v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Medtech
ApiFix Ltd
MD Ortho
Common Stock
Common Stock
Medtech
Common Stock
ApiFix Ltd
Common Stock
MD Ortho
Additional Paid-in Capital
Additional Paid-in Capital
Medtech
Additional Paid-in Capital
ApiFix Ltd
Additional Paid-in Capital
MD Ortho
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2021 $ 225,369       $ 5       $ 394,899       $ (178,026) $ 8,491
Beginning balance (in shares) at Dec. 31, 2021         19,677,214                  
Increase (Decrease) in Stockholders' Equity                            
Net loss (9,100)                       (9,100)  
Other comprehensive loss (2,751)                         (2,751)
Restricted stock 1,526               1,526          
Restricted stock (in shares)         144,084                  
Ending balance at Mar. 31, 2022 215,044       $ 5       396,425       (187,126) 5,740
Ending balance (in shares) at Mar. 31, 2022         19,821,298                  
Beginning balance at Dec. 31, 2021 225,369       $ 5       394,899       (178,026) 8,491
Beginning balance (in shares) at Dec. 31, 2021         19,677,214                  
Increase (Decrease) in Stockholders' Equity                            
Net loss (9,433)                          
Other comprehensive loss (12,175)                          
Ending balance at Jun. 30, 2022 227,216       $ 5       418,354       (187,459) (3,684)
Ending balance (in shares) at Jun. 30, 2022         20,238,870                  
Beginning balance at Mar. 31, 2022 215,044       $ 5       396,425       (187,126) 5,740
Beginning balance (in shares) at Mar. 31, 2022         19,821,298                  
Increase (Decrease) in Stockholders' Equity                            
Net loss (333)                       (333)  
Other comprehensive loss (9,424)                         (9,424)
Restricted stock 1,770               1,770          
Restricted stock (in shares)         57,180                  
Consideration for MedTech and MD Ortho acquisition       $ 9,707               $ 9,707    
Consideration for MedTech and MD Ortho acquisition (in shares)               173,241            
Stock portion of ApiFix anniversary installment     $ 10,410               $ 10,410      
Stock portion of ApiFix anniversary installment (in shares)             185,811              
Stock option exercise 42               42          
Stock option exercise (in shares)         1,340                  
Ending balance at Jun. 30, 2022 227,216       $ 5       418,354       (187,459) (3,684)
Ending balance (in shares) at Jun. 30, 2022         20,238,870                  
Beginning balance at Dec. 31, 2022 $ 378,648       $ 6       560,810       (176,768) (5,400)
Beginning balance (in shares) at Dec. 31, 2022 22,877,962       22,877,962                  
Increase (Decrease) in Stockholders' Equity                            
Net loss $ (6,806)                       (6,806)  
Other comprehensive loss (646)                         (646)
Restricted stock 1,959               1,959          
Restricted stock (in shares)         264,156                  
Ending balance at Mar. 31, 2023 373,155       $ 6       562,769       (183,574) (6,046)
Ending balance (in shares) at Mar. 31, 2023         23,142,118                  
Beginning balance at Dec. 31, 2022 $ 378,648       $ 6       560,810       (176,768) (5,400)
Beginning balance (in shares) at Dec. 31, 2022 22,877,962       22,877,962                  
Increase (Decrease) in Stockholders' Equity                            
Net loss $ (9,692)                          
Other comprehensive loss (2,511)                          
Ending balance at Jun. 30, 2023 $ 380,312       $ 6       574,677       (186,460) (7,911)
Ending balance (in shares) at Jun. 30, 2023 23,340,463       23,340,463                  
Beginning balance at Mar. 31, 2023 $ 373,155       $ 6       562,769       (183,574) (6,046)
Beginning balance (in shares) at Mar. 31, 2023         23,142,118                  
Increase (Decrease) in Stockholders' Equity                            
Net loss (2,886)                       (2,886)  
Other comprehensive loss (1,865)                         (1,865)
Restricted stock 3,456               3,456          
Restricted stock (in shares)         14,591                  
Consideration for MedTech and MD Ortho acquisition   $ 2,274               $ 2,274        
Consideration for MedTech and MD Ortho acquisition (in shares)           43,751                
Stock portion of ApiFix anniversary installment     $ 6,178               $ 6,178      
Stock portion of ApiFix anniversary installment (in shares)             140,003              
Ending balance at Jun. 30, 2023 $ 380,312       $ 6       $ 574,677       $ (186,460) $ (7,911)
Ending balance (in shares) at Jun. 30, 2023 23,340,463       23,340,463